{
    "Title": "CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis",
    "URL": "https://doi.org/10.1371/journal.pntd.0008050",
    "Published": "February 28, 2020",
    "Subject_Areas": [
        "Macaque",
        "Gene expression",
        "Lesions",
        "Biopsy",
        "Immune response",
        "Treatment guidelines",
        "Parasitic diseases",
        "Promastigotes"
    ],
    "Authors": {
        "Seth G Thacker": [
            "Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Ian L. McWilliams": [
            "Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Beatrice Bonnet": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Lydia Halie": [
            "Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Serge Beaucage": [
            "Laboratory of Biological Chemistry; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Swaksha Rachuri": [
            "Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Ranadhir Dey": [
            "Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Robert Duncan": [
            "Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Farrokh Modabber": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Stephen Robinson": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Graeme Bilbe": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Byron Arana": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Daniela Verthelyi": [
            "Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ]
    }
}